Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$2.59

0.01 (0.39%)

05:29
04/13/18
04/13
05:29
04/13/18
05:29

Pacific Biosciences Sequel installs could be light in Q1, says Piper Jaffray

Following his quarterly channel checks, Piper Jaffray analyst William Quirk lowered his estimated Sequel installs for Pacific Biosciences' Q1 to 26 from 30. The analyst believes there could be some risk to the quarter based on the light amount of suggested installs. Quirk keeps a Neutral rating on Pacific Biosciences with a $3.80 price target.

  • 21

    May

PACB Pacific Biosciences
$2.59

0.01 (0.39%)

07/20/17
PIPR
07/20/17
NO CHANGE
Target $4.8
PIPR
Neutral
Pacific Biosciences checks imply potential Q2 downside, says Piper Jaffray
Piper Jaffray analyst William Quirk says his channel checks found 13 Sequel systems in the quarter, down sequentially from 21 found in Q1 and 13 in Q4. Pacific Biosciences typically places two times the channel check, which would imply 26 systems in the quarter, Quirk tells investors in a research note. He lowered his 33 estimate to 30 and sees risk to Q2 numbers. The analyst keeps a Neutral rating on Pacific Biosciences and dropped his price target for the shares to $4.80 from $5.10.
09/28/17
KING
09/28/17
DOWNGRADE
KING
Neutral
Pacific Biosciences downgraded to Neutral from Buy at CL King
CL King analyst David Westenberg downgraded Pacific Biosciences to Neutral due to fair valuation and raised his fair value estimate to $6.80 from $5.60.
11/03/17
FANA
11/03/17
DOWNGRADE
Target $4
FANA
Equal-Weight
Pacific Biosciences downgraded to Equal-Weight at First Analysis
First Analysis analyst Joseph Munda downgraded Pacific Biosciences to Equal Weight from Overweight and cut his price target for the shares to $4 from $7. The analyst says concerns regarding competition and the company's sales strategy have begun to outweigh his positive view of its technology and opportunity following the Q3 sales miss and guidance reduction.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$106.14

3.455 (3.36%)

08:05
10/22/18
10/22
08:05
10/22/18
08:05
Upgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BSRR

Sierra Bancorp

$26.96

-0.06 (-0.22%)

08:05
10/22/18
10/22
08:05
10/22/18
08:05
Earnings
Sierra Bancorp reports Q3 EPS 46c, consensus 47c »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

, GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Tendril, Google collaborate for energy info for Indiana Michigan Power customers »

Tendril announced a new…

GOOG

Alphabet

$1,096.41

8.51 (0.78%)

GOOGL

Alphabet Class A

$1,104.66

7.43 (0.68%)

AEP

American Electric

$73.25

1.55 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 11

    Nov

  • 11

    Nov

  • 03

    Mar

ETTX

Entasis Therapeutics

$7.44

0.34 (4.79%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Initiation
Entasis Therapeutics initiated  »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$192.83

-3.91 (-1.99%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Breaking Hot Stocks news story on Lennox »

Lennox plans $100M of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EIGR

Eiger BioPharmaceuticals

$11.85

-0.18 (-1.50%)

08:04
10/22/18
10/22
08:04
10/22/18
08:04
Hot Stocks
Eiger BioPharmaceuticals' lonafarnib receives RPD designation from FDA »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

LII

Lennox

$192.83

-3.91 (-1.99%)

08:03
10/22/18
10/22
08:03
10/22/18
08:03
Earnings
Lennox cuts FY18 adjusted EPS view to $8.70-$9.10 from $8.90-$9.30 »

FY18 consensus $9.23.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BLMN

Bloomin' Brands

$19.57

-0.11 (-0.56%)

08:03
10/22/18
10/22
08:03
10/22/18
08:03
Hot Stocks
Barington calls on Bloomin' directors to improve board oversight of management »

Barington Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

KLXE

KLX Energy

$32.22

0.27 (0.85%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Conference/Events
KLX Energy to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MCD

McDonald's

$167.45

0.61 (0.37%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Recommendations
McDonald's analyst commentary  »

McDonald's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HON

Honeywell

$153.49

-1.73 (-1.11%)

08:02
10/22/18
10/22
08:02
10/22/18
08:02
Recommendations
Honeywell analyst commentary  »

Honeywell growth and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AROW

Arrow Financial

$34.92

-0.39 (-1.10%)

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Earnings
Arrow Financial reports Q3 EPS 64c, one estimate 65c »

Reports Q3 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$158.35

2.15 (1.38%)

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Hot Stocks
Accenture agrees to acquire New Content, terms not disclosed »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 28

    Oct

  • 13

    Nov

MCRB

Seres Therapeutics

08:01
10/22/18
10/22
08:01
10/22/18
08:01
Initiation
Seres Therapeutics initiated  »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$11.05

-0.425 (-3.71%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
Cleveland-Cliffs analyst commentary  »

Cleveland-Cliffs dividend…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$77.74

-9.33 (-10.72%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
VF Corp. analyst commentary  »

VF Corp. near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVAX

Dynavax

$10.90

-0.47 (-4.13%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Recommendations
Dynavax analyst commentary  »

Dynavax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LII

Lennox

$192.83

-3.91 (-1.99%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Earnings
Lennox reports Q3 adjusted EPS $2.72, consensus $2.92 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

YNDX

Yandex

$27.42

-2.07 (-7.02%)

08:00
10/22/18
10/22
08:00
10/22/18
08:00
Options
Yandex put buyer realizes 65% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

ENIA

Enel Americas

$7.73

0.01 (0.13%)

07:59
10/22/18
10/22
07:59
10/22/18
07:59
Initiation
Enel Americas initiated  »

Morgan Stanley resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNFI

United Natural Foods

$26.78

-0.16 (-0.59%)

, SVU

Supervalu

$32.50

0.01 (0.03%)

07:57
10/22/18
10/22
07:57
10/22/18
07:57
Recommendations
United Natural Foods, Supervalu analyst commentary  »

United Natural Foods…

UNFI

United Natural Foods

$26.78

-0.16 (-0.59%)

SVU

Supervalu

$32.50

0.01 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SU

Suncor

$35.73

0.24 (0.68%)

07:55
10/22/18
10/22
07:55
10/22/18
07:55
Upgrade
Suncor rating change  »

Suncor upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

VIOT

Viomi Technology

$8.11

-0.21 (-2.52%)

07:55
10/22/18
10/22
07:55
10/22/18
07:55
Initiation
Viomi Technology initiated  »

Viomi Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$116.01

0.11 (0.09%)

07:55
10/22/18
10/22
07:55
10/22/18
07:55
Technical Analysis
SPDR Gold Trust: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$40.04

-1.82 (-4.35%)

07:55
10/22/18
10/22
07:55
10/22/18
07:55
Hot Stocks
Mirati Therapeutics provides sitravatinib update after meeting with FDA »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.